文献速递糖尿病

胰岛素原肽在新型HLA-DR3-DQ2转基因小鼠模型中促进自发自身免疫性糖尿病

Proinsulin peptide promotes autoimmune diabetes in a novel HLA-DR3-DQ2-transgenic murine model of spontaneous disease.
PubMed 文献 · Diabetologia · 2019-10-14

研究构建了表达1型糖尿病高危HLA基因(DRB1*03:01-DQA1*05:01-DQB1*02:01)及人CD80、CD4的C57BL/6小鼠模型,该模型自发产生自身免疫性糖尿病(35周龄发病率为46%)。经佐剂抗原初免后,胰岛素原肽可显著加速疾病并提高外显率,其致糖尿病区域定位于15个残基的B29-C11片段。

要点

  • 新型HLA-DR3-DQ2+huCD4+IA/IE-/-RIP.B7.1+小鼠可自发自身免疫性糖尿病,35周龄发病率46%。
  • 胰岛素原佐剂初免后疾病加速,平均发病11周,攻击后20周发病率100%。
  • 致糖尿病效应定位于胰岛素原B29-C11的15个残基区域。

核心结论

  • 在HLA-DR3-DQ2背景下,胰岛素原来源的特定肽段具有高度致糖尿病性。

研究设计与样本

  • 研究构建了表达DRB1*03:01-DQA1*05:01-DQB1*02:01、人CD80(大鼠胰岛素启动子驱动)和人CD4的C57BL/6背景HLA转基因小鼠模型。
  • 采用佐剂抗原初免揭示候选抗原和肽段的致糖尿病性。

主要发现

  • HLA-DR3-DQ2+huCD4+IA/IE-/-RIP.B7.1+小鼠自发自身免疫性糖尿病,35周龄发病率为46%。
  • 小鼠出现针对GAD65和胰岛素原的自身抗体,胰岛被CD4+、CD8+、B220+、CD11b+和CD11c+免疫细胞浸润。
  • 胰岛素原佐剂初免后疾病显著加速,平均发病11周,攻击后20周发病率100%。
  • 致糖尿病效应定位于胰岛素原B29-C11的15个残基区域。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS/HYPOTHESIS: The molecular basis for the pathological impact of specific HLA molecules on autoimmune diseases such as type 1 diabetes remains unclear. Recent natural history studies in children have indicated a link between specific HLA genotypes and the first antigenic target against which immune responses develop. We set out to examine this link in vivo by exploring the diabetogenicity of islet antigens on the background of a common diabetes-associated HLA haplotype. METHODS: We generated a novel HLA-transgenic mouse model that expresses high-risk genes for type 1 diabetes (DRB1*03:01-DQA1*05:01-DQB1*02:01) as well as human CD80 under the rat insulin promoter and human CD4, on a C57BL/6 background. Adjuvanted antigen priming was used to reveal the diabetogenicity of candidate antigens and peptides. RESULTS: HLA-DR3-DQ2+huCD4+IA/IE-/-RIP.B7.1+ mice spontaneously developed autoimmune diabetes (incidence 46% by 35 weeks of age), accompanied by numerous hallmarks of human type 1 diabetes (autoantibodies against GAD65 and proinsulin; pancreatic islet infiltration by CD4+, CD8+ B220+, CD11b+ and CD11c+ immune cells). Disease was markedly accelerated and had deeper penetrance after adjuvanted antigen priming with proinsulin (mean onset 11 weeks and incidence 100% by 20 weeks post challenge). Moreover, the diabetogenic effect of proinsulin located to the 15-residue B29-C11 region. CONCLUSIONS/INTERPRETATION: Our study identifies a proinsulin-derived peptide region that is highly diabetogenic on the HLA-DR3-DQ2 background using an in vivo model. This approach and the peptide region identified may have wider implications for future studies of human type 1 diabetes.

来源:Diabetologia,查看原文。版权归原作者所有。

引用

  1. Verhagen J, Yusuf N, Smith EL, et al. Proinsulin peptide promotes autoimmune diabetes in a novel HLA-DR3-DQ2-transgenic murine model of spontaneous disease. Diabetologia. 2019. PMID: 31612266. doi:10.1007/s00125-019-04994-8

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。